Diagnosis and treatment of acute or persistent diarrhea

Sean W Pawlowski, Cirle Alcantara Warren, Richard Guerrant, Sean W Pawlowski, Cirle Alcantara Warren, Richard Guerrant

Abstract

Studies of microbial pathogens and the toxins they produce are important for determining the mechanisms by which they cause disease and spread throughout a population. Some bacteria produce secretory enterotoxins (such as cholera toxin or the heat-labile or stable enterotoxins produced by Escherichia coli) that invade cells directly. Others invade cells or produce cytotoxins (such as those produced by Shigella, enteroinvasive E coli, or Clostridium difficile) that damage cells or trigger host responses that cause small or large bowel diseases (such as enteroaggregative or enteropathogenic E coli or Salmonella). Viruses (such as noroviruses and rotaviruses) and protozoa (such as Cryptosporidium, Giardia, or Entamoeba histolytica) disrupt cell functions and cause short- or long-term disease. Much epidemiologic data about these pathogens have been collected from community- and hospital-acquired settings, as well as from patients with traveler's or persistent diarrhea. These studies have led to practical approaches for prevention, diagnosis, and treatment.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7172731/bin/grr1_lrg.jpg
Sean W. Pawlowski
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7172731/bin/grr2_lrg.jpg
Cirle Alcantara Warren
https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7172731/bin/grr3_lrg.jpg
Richard Guerrant
Figure 1
Figure 1
Normal intestinal physiology and alteration by pathogens and their toxins. The average oral intake for an adult is 1.5 L fluid/day. Combined with salivary, gastric, biliary, and pancreatic secretions 7 L fluid enter the upper small bowel each day, most of which is absorbed by the time it reaches the distal small bowel. However, this small bowel fluid is mixed with a remarkable bidirectional flux of water and electrolytes in the upper small bowel that probably exceeds 50 L isotonic fluid each day, to aid in the absorption of digested dietary intake.. This striking bidirectional electrolyte transport is driven by an active, adenosine triphosphate (ATP)–dependent active sodium (Na) absorption pump located on the basolateral membranes of both intestinal crypt and villus tip cells (middle). Because the chloride (Cl−) channel is located on the luminal surface of the crypt cells, this Na pump mediates secretion of Cl− (along with Na and water) from the crypts and neutral NaCl absorption in the differentiated villus tip cells. Thus, a relatively slight shift in this large bidirectional flux can readily overload the colonic absorptive capacity, which rarely exceeds 2–3 L/day. Like cholera toxin (CT), E coli heat-labile toxin (LT) opens Cl− channels, leading to secretory watery diarrhea or traveler's diarrhea. The E coli heat-stable toxin (ST) activates guanylate cyclase to increase intracellular cyclic guanosine monophosphate (cGMP) levels, inhibiting NaCl absorption and leading to secretory diarrhea. Selective damage of absorptive villus tips, which occurs in viral, protozoal, and other villus-damaging or inflammatory processes, leaves unbalanced secretory crypts that are not offset by healthy villus tip absorption, also leading to watery diarrhea. Small bowel pathogens are presented in the right panels: those that produce secretory enterotoxins are in the red box, those that selectively disrupt absorptive villus tips are in the green box, and ileocolonic pathogens are in the tan box.
Figure 2
Figure 2
Diagnosis, treatment, and causes of diarrheal diseases. For patients with diarrheal illnesses, it is important to first adequately assess the patient and determine the level of dehydration (panel 1). Important factors include duration of illness; alertness, skin turgor, mucous membrane dryness, sunken eyes or fontanelles, and postural hypotension all indicate moderate or severe hypovolemia and dehydration; signs of inflammation include fever, bloody stool, and tenesmus. In cases of dehydration (panel 2), patients can be rehydrated by oral administration of fluids that contain glucose, sugar or starch, and electrolytes; and patients can be given bismuth subsalicylate or loperamide if their diarrhea is not bloody (panel 2). If patients are unconscious or vomiting, fluids should be replaced intravenously. Pediatric patients can be given an oral rehydration solution made of sodium chloride, sodium bicarbonate, potassium chloride, and glucose or glucose polymer (such as sucrose) in water. Or, table salt and sugar can be added to orange juice, and bananas can be added to provide potassium. There are a number of epidemiologic and clinical clues that can be used to identify the infectious agent (panel 3). Epidemiologic factors that should be considered include the food that patients have eaten (raw, undercooked meats, raw seafood), antibiotics taken (especially for C difficile infection), sexual practices (men who have sex with men might have proctitis or colitis with sexually transmitted pathogens), and recent travel (indicate bacterial pathogens such as enterotoxigenic E coli, Salmonella, Shigella, and Campylobacter; persistent diarrhea can be caused by protozoans such as Giardia or Cryptosporidium). Outbreaks of viral-related (norovirus or rotavirus) disease or those caused by organisms with relatively low-infectious inocula that are spread by fecal oral contact, such as Shigella, Giardia, and Cryptosporidium, are most commonly observed in day care settings. Other epidemiologic clues include immunoglobulin A deficiency, which predisposes to giardiasis, and immunosuppression (particularly in patients with AIDS), which can lead to protozoal infections, Mycobacterium avium complex, and intestinal cytomegalovirus infections. Clinical features can also be used to identify the infectious agent. Bloody diarrhea is associated with Shiga toxin-producing E coli, Shigella and E histolytica infections; abdominal pain with Yersinia and some C difficile infections; dysentery with Shigella or Campylobacter infection; wasting with Giardia or Cryptosporidium infection; and fecal inflammation with Shigella, Campylobacter, Salmonella, and some E coli and C difficile infections.
Figure 3
Figure 3
An algorithm for severe, bloody, inflammatory, or outbreak-related infectious diarrhea. In addition to the management of fluid and electrolyte imbalances, nonsecretory or outbreak-related diarrhea may need further workup for definitive causative diagnoses and pathogen-directed therapy. Depending on the epidemiologic setting involved and likely causes, specific diagnostic tests are suggested as discussed in the text. Specific bacteria such as Campylobacter, Shigella, or C difficile and protozoa such as Cryptosporidium, Giardia, or Cyclospora may require specific antibacterial or antiparasitic agents, respectively. Empiric antimicrobial therapy, while awaiting laboratory test results, is usually appropriate for these pathogens. However, antibacterial treatment may worsen diarrhea secondary to EHEC (eg, E coli 0157:H7), which usually presents with noninflammatory, bloody diarrhea.

References

    1. Guerrant R.L., Kosek M., Lima A.A., Lorntz B., Guyatt H.L. Updating the DALYs for diarrhoeal disease. Trends Parasitol. 2002;18:191–193. May.
    1. Checkley W., Buckley G., Gilman R.H. Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol. 2008;37:816–830.
    1. Nataro J.P., Mai V., Johnson J. Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut. Clin Infect Dis. 2006;43:402–407.
    1. Brito G.A., Alcantara C., Carneiro-Filho B.A., Guerrant R.L. Pathophysiology and impact of enteric bacterial and protozoal infections: new approaches to therapy. Chemotherapy. 2005;51(Suppl 1):23–35.
    1. Lucas M.L., Duncan N.W., O'Reilly N.F., McIlvenny T.J., Nelson Y.B. Lack of evidence in vivo for a remote effect of Escherichia coli heat stable enterotoxin on jejunal fluid absorption. Neurogastroenterol Motil. 2008;20:532–538.
    1. Lucas M.L. Enterocyte chloride and water secretion into the small intestine after enterotoxin challenge: unifying hypothesis or intellectual dead end? J Physiol Biochem. 2008;64:69–88.
    1. Jiang Z.D., Okhuysen P.C., Guo D.C. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promotor region. J Infect Dis. 2003;188(4):506–511.
    1. Steiner T.S., Lima A.A., Nataro J.P., Guerrant R.L. Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J Infect Dis. 1998;177:88–96.
    1. Dionisio D., Manneschi L.I., di Lollo S. Strongyloides stercoralis: ultrastructural study of newly hatched larvae within human duodenal mucosa. J Clin Pathol. 2000;53:110–116.
    1. Ruest N., Couture Y., Faubert G.M., Girard C. Morphological changes in the jejunum of calves naturally infected with Giardia spp. and Cryptosporidium spp. Vet Parasitol. 1997;69:177–186.
    1. Iijima Y., Tanaka S., Miki K., Kanamori S., Toyokawa M., Asari S. Evaluation of colony-based examinations of diarrheagenic Escherichia coli in stool specimens: low probability of detection because of low concentrations, particularly during the early stage of gastroenteritis. Diagn Microbiol Infect Dis. 2007;58:303–308.
    1. Garcia L.S., Shimizu R.Y. Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens. J Clin Microbiol. 1997;35:1526–1529.
    1. Haque R., Roy S., Siddique A. Multiplex real-time PCR assay for detection of Entamoeba histolytica, Giardia intestinalis, and Cryptosporidium spp. Am J Trop Med Hyg. 2007;76:713–717.
    1. Parr J.B., Sevilleja J.E., Amidou S. Detection and quantification of Cryptosporidium in HCT-8 cells and human fecal specimens using real-time polymerase chain reaction. Am J Trop Med Hyg. 2007;76:938–942.
    1. ten H.R., Schuurman T., Kooistra M., Moller L., van L.L., Verweij J.J. Detection of diarrhoea-causing protozoa in general practice patients in The Netherlands by multiplex real-time PCR. Clin Microbiol Infect. 2007;13:1001–1007.
    1. Bass E.S., Pappano D.A., Humiston S.G. Rotavirus. Pediatr Rev. 2007;28:183–191.
    1. Radford A.D., Gaskell R.M., Hart C.A. Human norovirus infection and the lessons from animal caliciviruses. Curr Opin Infect Dis. 2004;17:471–478.
    1. Nhung P.H., Ohkusu K., Miyasaka J., Sun X.S., Ezaki T. Rapid and specific identification of 5 human pathogenic Vibrio species by multiplex polymerase chain reaction targeted to dnaJ gene. Diagn Microbiol Infect Dis. 2007;59:271–275.
    1. Kim J.S., Lee G.G., Park JS B. A novel multiplex PCR assay for rapid and simultaneous detection of five pathogenic bacteria: Escherichia coli O157:H7, Salmonella, Staphylococcus aureus, Listeria monocytogenes, and Vibrio parahaemolyticus. J Food Prot. 2007;70:1656–1662.
    1. Paton A.W., Paton J.C. Multiplex PCR for direct detection of Shiga toxigenic Escherichia coli strains producing the novel subtilase cytotoxin. J Clin Microbiol. 2005;43:2944–2947.
    1. Finkbeiner S.R., Allred A.F., Tarr P.I., Klein E.J., Kirkwood C.D., Wang D. Metagenomic analysis of human diarrhea: viral detection and discovery. PLoS Pathog. 2008;4:e1000011.
    1. Al-Gallas N., Bahri O., Bouratbeen A., Ben H.A., Ben A.R. Etiology of acute diarrhea in children and adults in Tunis, Tunisia, with emphasis on diarrheagenic Escherichia coli: prevalence, phenotyping, and molecular epidemiology. Am J Trop Med Hyg. 2007;77:571–582.
    1. Vernacchio L., Vezina R.M., Mitchell A.A., Lesko S.M., Plaut A.G., Acheson D.W. Diarrhea in American infants and young children in the community setting: incidence, clinical presentation and microbiology. Pediatr Infect Dis J. 2006;25:2–7.
    1. Widdowson M.A., Bresee J.S., Gentsch J.R., Glass R.I. Rotavirus disease and its prevention. Curr Opin Gastroenterol. 2005;21:26–31.
    1. Johnston C.P., Qiu H., Ticehurst J.R. Outbreak management and implications of a nosocomial norovirus outbreak. Clin Infect Dis. 2007;45:534–540.
    1. Glass R.I., Noel J., Ando T. The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. J Infect Dis. 2000;181(Suppl 2):S254–S261.
    1. UNICEF . UNICEF; New York, NY: 2008. The state of the world's children.
    1. Bryce J., Boschi-Pinto C., Shibuya K., Black R.E. WHO estimates of the causes of death in children. Lancet. 2005;365:1147–1152.
    1. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9:565–572.
    1. Lopman B., Zambon M., Brown D.W. The evolution of norovirus, the ”gastric flu. PLoS Med. 2008;5:e42.
    1. Lindesmith L.C., Donaldson E.F., Lobue A.D. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 2008;5:e31.
    1. Noren T., Akerlund T., Back E. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol. 2004;42:3635–3643.
    1. Svenungsson B., Burman L.G., Jalakas-Pornull K., Lagergren A., Struwe J., Akerlund T. Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital. J Clin Microbiol. 2003;41:4031–4037.
    1. Price M.F., Dao-Tran T., Garey K.W. Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital. J Hosp Infect. 2007;65:42–46.
    1. World Health Organization . World Health Organization; 2008. Cholera surveillance and number of cases. Accessed April 2, 2009.
    1. Kosek M., Bern C., Guerrant R.L. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ. 2003;81:197–204.
    1. Guerrant R.L., Kosek M., Moore S., Lorntz B., Brantley R., Lima A.A. Magnitude and impact of diarrheal diseases. Arch Med Res. 2002;33:351–355.
    1. Karanis P., Kourenti C., Smith H. Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt. J Water Health. 2007;5:1–38.
    1. Petri W.A., Jr, Haque R., Lyerly D., Vines R.R. Estimating the impact of amebiasis on health. Parasitol Today. 2000;16:320–321.
    1. Moore S.R., Lima A.A., Conaway M.R., Schorling J.B., Soares A.M., Guerrant R.L. Early childhood diarrhoea and helminthiases associate with long-term linear growth faltering. Int J Epidemiol. 2001;30:1457–1464.
    1. Centers for Disease Control and Prevention Outbreak of cyclosporiasis associated with snow peas–Pennsylvania, 2004. MMWR Morb Mortal Wkly Rep. 2004;53:876–878.
    1. Ho A.Y., Lopez A.S., Eberhart M.G. Outbreak of cyclosporiasis associated with imported raspberries, Philadelphia, Pennsylvania, 2000. Emerg Infect Dis. 2002;8:783–788.
    1. Lopez A.S., Dodson D.R., Arrowood M.J. Outbreak of cyclosporiasis associated with basil in Missouri in 1999. Clin Infect Dis. 2001;32:1010–1017.
    1. Katz D., Kumar S., Malecki J., Lowdermilk M., Koumans E.H., Hopkins R. Cyclosporiasis associated with imported raspberries, Florida, 1996. Public Health Rep. 1999;114:427–438.
    1. Herwaldt B.L., Ackers M.L. An outbreak in 1996 of cyclosporiasis associated with imported raspberries: The Cyclospora Working Group. N Engl J Med. 1997;336:1548–1556.
    1. Caceres V.M., Ball R.T., Somerfeldt S.A. A foodborne outbreak of cyclosporiasis caused by imported raspberries. J Fam Pract. 1998;47:231–234.
    1. Hoxie N.J., Davis J.P., Vergeront J.M., Nashold R.D., Blair K.A. Cryptosporidiosis-associated mortality following a massive waterborne outbreak in Milwaukee, Wisconsin. Am J Public Health. 1997;87:2032–2035.
    1. Houpt E.R., Bushen O.Y., Sam N.E. Short report: asymptomatic Cryptosporidium hominis infection among human immunodeficiency virus-infected patients in Tanzania. Am J Trop Med Hyg. 2005;73:520–522.
    1. Volz C.D., Christen C. Occupational medicine forum. J Occup Environ Med. 2008;49:104–105.
    1. Weinke T., Friedrich-Janicke B., Hopp P., Janitschke K. Prevalence and clinical importance of Entamoeba histolytica in two high-risk groups: travelers returning from the tropics and male homosexuals. J Infect Dis. 1990;161:1029–1031.
    1. Simor A.E., Bradley S.F., Strausbaugh L.J., Crossley K., Nicolle L.E. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol. 2002;23:696–703.
    1. Riggs M.M., Sethi A.K., Zabarsky T.F., Eckstein E.C., Jump R.L., Donskey C.J. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis. 2007;45:992–998.
    1. Zilberberg M.D., Shorr A.F., Kollef M.H. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis. 2008;14:929–931.
    1. Redelings M.D., Sorvillo F., Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis. 2007;13:1417–1419.
    1. Akerlund T., Persson I., Unemo M. Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol. 2008;46:1530–1533.
    1. Iwai S., Akutsu M. [Severe infection in gastroenterological field; MRSA (methicillin resistant Staphylococcus aureus) enterocolitis] Nippon Rinsho. 1994;52:456–461. [in Japanese].
    1. Wall P.G., Ryan M.J., Ward L.R., Rowe B. Outbreaks of salmonellosis in hospitals in England and Wales: 1992-1994. J Hosp Infect. 1996;33:181–190.
    1. Kordidarian R., Kelishadi R., Arjmandfar Y. Nosocomial infection due to rotavirus in infants in Alzahra Hospital, Isfahan, Iran. J Health Popul Nutr. 2007;25:231–235.
    1. Rayani A., Bode U., Habas E. Rotavirus infections in paediatric oncology patients: a matched-pairs analysis. Scand J Gastroenterol. 2007;42:81–87.
    1. Gleizes O., Desselberger U., Tatochenko V. Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease. Pediatr Infect Dis J. 2006;25(1 Suppl):S12–S21.
    1. Widdowson M.A., van Doornum G.J., van der Poel W.H., de Boer A.S., Mahdi U., Koopmans M. Emerging group-A rotavirus and a nosocomial outbreak of diarrhoea. Lancet. 2000;356:1161–1162.
    1. Rogers M., Weinstock D.M., Eagan J., Kiehn T., Armstrong D., Sepkowitz K.A. Rotavirus outbreak on a pediatric oncology floor: possible association with toys. Am J Infect Control. 2000;28:378–380.
    1. Neill M.A., Rice S.K., Ahmad N.V., Flanigan T.P. Cryptosporidiosis: an unrecognized cause of diarrhea in elderly hospitalized patients. Clin Infect Dis. 1996;22:168–170.
    1. Navarrete S., Stetler H.C., Avila C., Garcia Aranda J.A., Santos-Preciado J.I. An outbreak of Cryptosporidium diarrhea in a pediatric hospital. Pediatr Infect Dis J. 1991;10:248–250.
    1. Baxby D., Hart C.A., Taylor C. Human cryptosporidiosis: a possible case of hospital cross infection. Br Med J (Clin Res Ed) 1983;287:1760–1761.
    1. Ravn P., Lundgren J.D., Kjaeldgaard P. Nosocomial outbreak of cryptosporidiosis in AIDS patients. BMJ. 1991;302:277–280.
    1. Aygun G., Yilmaz M., Yasar H. Parasites in nosocomial diarrhoea: are they underestimated? J Hosp Infect. 2005;60:283–285.
    1. Zaidi M., Ponce de L.S., Ortiz R.M. Hospital-acquired diarrhea in adults: a prospective case-controlled study in Mexico. Infect Control Hosp Epidemiol. 1991;12:349–355.
    1. Gikas A., Kritsotakis E.I., Maraki S. A nosocomial, foodborne outbreak of Salmonella Enterica serovar Enteritidis in a university hospital in Greece: the importance of establishing HACCP systems in hospital catering. J Hosp Infect. 2007;66:194–196.
    1. Dryden M.S., Keyworth N., Gabb R., Stein K. Asymptomatic foodhandlers as the source of nosocomial salmonellosis. J Hosp Infect. 1994;28:195–208.
    1. Alam N.K., Armstrong P.K., Nguyen O.T., Kesson A.M., Cripps T.M., Corbett S.J. Salmonella typhimurium phage type 170 in a tertiary paediatric hospital with person-to-person transmission implicated. Commun Dis Intell. 2005;29:374–378.
    1. Matsuoka D.M., Costa S.F., Mangini C. A nosocomial outbreak of Salmonella enteritidis associated with lyophilized enteral nutrition. J Hosp Infect. 2004;58:122–127.
    1. Bornemann R., Zerr D.M., Heath J. An outbreak of Salmonella serotype Saintpaul in a children's hospital. Infect Control Hosp Epidemiol. 2002;23:671–676.
    1. Delaloye J., Merlani G., Petignat C. Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization? Eur J Clin Microbiol Infect Dis. 2004;23:751–758. C.
    1. Wadula J., von Gottberg A., Kilner D. Nosocomial outbreak of extended-spectrum beta-lactamase-producing Salmonella isangi in pediatric wards. Pediatr Infect Dis J. 2006;25:843–844.
    1. Bouallegue-Godet O., Ben S.Y., Fabre L. Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum beta-lactamase in a neonatal unit in Sousse, Tunisia. J Clin Microbiol. 2005;43:1037–1044.
    1. Hill D.R. Health problems in a large cohort of Americans traveling to developing countries. J Travel Med. 2000;7:259–266.
    1. Steffen R. Epidemiology of traveler's diarrhea. Clin Infect Dis. 2005;41(Suppl 8):S536–S540.
    1. Tjoa W.S., DuPont H.L., Sullivan P. Location of food consumption and travelers' diarrhea. Am J Epidemiol. 1977;106:61–66.
    1. Gorbach S.L. How to hit the runs for fifty million travelers at risk. Ann Intern Med. 2005;142:861–862.
    1. Ilnyckyj A., Balachandra B., Elliott L., Choudhri S., Duerksen D.R. Post-traveler's diarrhea irritable bowel syndrome: a prospective study. Am J Gastroenterol. 2003;98:596–599.
    1. Okhuysen P.C., Jiang Z.D., Carlin L., Forbes C., DuPont H.L. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol. 2004;99:1774–1778.
    1. DuPont H.L. New insights and directions in travelers' diarrhea. Gastroenterol Clin North Am. 2006;35 337–ix.
    1. Centers for Disease Control and Prevention . Prevention of specific infectious diseases. In: Arguin P.M., Kozarsky P.E., Reed C., editors. CDC health information for international travel 2008. 2008 ed. Elsevier; Philadelphia, PA: 2008. pp. 114–362.
    1. Neal K.R., Scott H.M., Slack R.C., Logan R.F. Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study. BMJ. 1996;312:414–415.
    1. Van De Winkel K., Van den Daele A., Van Gompel A., Van den Ende J. Factors influencing standard pretravel health advice--a study in Belgium. J Travel Med. 2007;14:288–296.
    1. Kozicki M., Steffen R., Schar M. 'Boil it, cook it, peel it or forget it': does this rule prevent travellers' diarrhoea? Int J Epidemiol. 1985;14:169–172.
    1. Shlim D.R. Looking for evidence that personal hygiene precautions prevent traveler's diarrhea. Clin Infect Dis. 2005;41(Suppl 8):S531–S535.
    1. Koo H.L., Jiang Z.D., Brown E., Garcia C., Qi H., DuPont H.L. Coliform contamination of vegetables obtained from popular restaurants in Guadalajara, Mexico, and Houston, Texas. Clin Infect Dis. 2008;47:218–221.
    1. Bandres J.C., Mathewson J.J., DuPont H.L. Heat susceptibility of bacterial enteropathogens: Implications for the prevention of travelers' diarrhea. Arch Intern Med. 1988;148:2261–2263.
    1. McFarland L.V. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis. 2007;5:97–105.
    1. DuPont H.L., Ericsson C.D., Johnson P.C., Bitsura J.A., DuPont M.W., de la Cabada F.J. Prevention of travelers' diarrhea by the tablet formulation of bismuth subsalicylate. JAMA. 1987;257:1347–1350.
    1. Steffen R., DuPont H.L., Heusser R. Prevention of traveler's diarrhea by the tablet form of bismuth subsalicylate. Antimicrob Agents Chemother. 1986;29:625–627.
    1. DuPont H.L., Sullivan P., Evans D.G. Prevention of traveler's diarrhea (emporiatric enteritis): Prophylactic administration of subsalicylate bismuth. JAMA. 1980;243:237–241.
    1. Graham D.Y., Estes M.K., Gentry L.O. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers. Gastroenterology. 1983;85:1017–1022.
    1. DuPont H.L., Jiang Z.D., Okhuysen P.C. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med. 2005;142:805–812.
    1. Adachi J.A., Mathewson J.J., Jiang Z.D., Ericsson C.D., DuPont H.L. Enteric pathogens in Mexican sauces of popular restaurants in Guadalajara, Mexico, and Houston, Texas. Ann Intern Med. 2002;136:884–887.
    1. DuPont H.L., Ericsson C.D., DuPont M.W. Emporiatric enteritis: lessons learned from U.S. students in Mexico. Trans Am Clin Climatol Assoc. 1986;97:32–42.
    1. Mattila L., Siitonen A., Kyronseppa H. Seasonal variation in etiology of travelers' diarrhea: Finnish-Moroccan Study Group. J Infect Dis. 1992;165:385–388.
    1. Okhuysen P.C. Traveler's diarrhea due to intestinal protozoa. Clin Infect Dis. 2001;33:110–114.
    1. Taylor D.N., Houston R., Shlim D.R., Bhaibulaya M., Ungar B.L., Echeverria P. Etiology of diarrhea among travelers and foreign residents in Nepal. JAMA. 1988;260:1245–1248.
    1. Svenungsson B., Lagergren A., Ekwall E. Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin Infect Dis. 2000;30:770–778.
    1. Freedman D.O., Weld L.H., Kozarsky P.E. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006;354:119–130.
    1. Frachtman R.L., Ericsson C.D., DuPont H.L. Seroconversion to Entamoeba histolytica among short-term travelers to Mexico. Arch Intern Med. 1982;142:1299.
    1. Bouckenooghe A.R., Jiang Z.D., de la Cabada F.J., Ericsson C.D., DuPont H.L. Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico. J Travel Med. 2002;9:137–140.
    1. Shlim D.R., Hoge C.W., Rajah R., Rabold J.G., Echeverria P. Is Blastocystis hominis a cause of diarrhea in travelers?: A prospective controlled study in Nepal. Clin Infect Dis. 1995;21:97–101.
    1. Ko G., Garcia C., Jiang Z.D. Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J Clin Microbiol. 2005;43:6126–6129.
    1. Chapin A.R., Carpenter C.M., Dudley W.C. Prevalence of norovirus among visitors from the United States to Mexico and Guatemala who experience traveler's diarrhea. J Clin Microbiol. 2005;43:1112–1117.
    1. Jiang Z.D., Lowe B., Verenkar M.P. Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay) J Infect Dis. 2002;185:497–502.
    1. Helbok R., Dent W., Gattringer K., Innerebner M., Schmutzhard E. Imported Dengue fever presenting with febrile diarrhoea: report of two cases. Wien Klin Wochenschr. 2004;116(Suppl 4):58–60.
    1. Shlim D.R., Hoge C.W., Rajah R., Scott R.M., Pandy P., Echeverria P. Persistent high risk of diarrhea among foreigners in Nepal during the first 2 years of residence. Clin Infect Dis. 1999;29:613–616.
    1. Gupta S., Narang S., Nunavath V., Singh S. Chronic diarrhoea in HIV patients: prevalence of coccidian parasites. Indian J Med Microbiol. 2008;26:172–175.
    1. Arenas-Pinto A., Certad G., Ferrara G., Castro J., Bello M.A., Nunez L.T. Association between parasitic intestinal infections and acute or chronic diarrhoea in HIV-infected patients in Caracas, Venezuela. Int J STD AIDS. 2003;14:487–492.
    1. Joshi M., Chowdhary A.S., Dalal P.J., Maniar J.K. Parasitic diarrhoea in patients with AIDS. Natl Med J India. 2002;15:72–74.
    1. Tumwine J.K., Kekitiinwa A., Bakeera-Kitaka S. Cryptosporidiosis and microsporidiosis in Ugandan children with persistent diarrhea with and without concurrent infection with the human immunodeficiency virus. Am J Trop Med Hyg. 2005;73:921–925.
    1. Thabane M., Kottachchi D.T., Marshall J.K. Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:535–544.
    1. Parry S.D., Corbett S., James P., Barton J.R., Welfare M.R. Illness perceptions in people with acute bacterial gastro-enteritis. J Health Psychol. 2003;8:693–704.
    1. Gwee K.A., Collins S.M., Read N.W. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut. 2003;52:523–526.
    1. Gwee K.A., Graham J.C., McKendrick M.W. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet. 1996;347:150–153.

Source: PubMed

3
Předplatit